Rainer Eugen Martin

This inventor holds 58 USPTO granted patents and 17 published patent applications, plus 2 CIPO patents and 33 EPO patents, primarily in Heterocyclic Compounds (CPC class C07D). Top assignees: Hoffmann-La Roche Inc., Cambridge Display Technology Limited, F. Hoffmann-La Roche Ag. Active years: 2005-2024.

USPTO Granted Patents = 58 (Patent Applications = 17)

% Patents Active = 46.6

CIPO Patents = 2 (Patent Applications = 13)

EPO Patents = 33 (Patent Applications = 57)

Average Co-Inventor Count = 6.2

ph-index = 6

Forward Citations = 99(Granted Patents)

Forward Citations (Not Self Cited) = 90(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Grenzach/Wyhlen, DE (2006)
Grenzach-Wyhlen, AT (2010)
Grenzach-Wyhlen, DE (2011 - 2013)
Basel, CH (2005 - 2024)

Company Filing History:

55 out of 5,011

Hoffmann-La Roche Inc.

patents

2 out of 335

Cambridge Display Technology Limited

patents

1 out of 180

F. Hoffmann-La Roche Ag

patents

Years Active: 2005-2024

Loading Chart...

Areas of Expertise:

Heterocyclic Compounds

Pyridines

Benzimidazole Derivatives

Triazoles

Aldosterone Synthase Inhibitors

GPBAR1 Agonists

Phenoxymethyl Derivatives

Spirodiamine Derivatives

Isoquinoline Derivatives

Ethynyl Derivatives

Phenyl-Dihydropyridine Derivatives

Dihydroquinoline Compounds

58 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11981661 - Heterocyclic compounds (2024-05-14),

2. 11814375 - Heterocyclic compounds (2023-11-14),

3. 11352330 - Phenoxymethyl derivatives (2022-06-07),

4. 10676446 - Bicyclic quinazolinone derivatives (2020-06-09),

5. 10640472 - Phenoxymethyl derivatives (2020-05-05),

6. 10457686 - [1,2,3]triazolo[4,5-D]pyrimidine derivatives (2019-10-29),

7. 10457685 - [1,2,3]triazolo[4,5-D]pyrimidine derivatives with affinity for the type-2 cannabinoid receptor (2019-10-29),

8. 10457684 - [1,2,3]triazolo[4,5-d]pyrimidine derivatives (2019-10-29),

9. 10450321 - [1,2,3]triazolo[4,5-D]pyrimidine derivatives (2019-10-22),

10. 10385022 - 3-amino-pyridines as GPBAR1 agonists (2019-08-20),

11. 10377719 - Trypanosomes inhibitors (2019-08-13),

12. 10035804 - Spirodiamine derivatives as aldosterone synthase inhibitors (2018-07-31),

13. 9797891 - Method and system for determining a biological response of a target to a soluble candidate substance (2017-10-24),

14. 9796726 - Dihydroquinoline pyrazolyl compounds (2017-10-24),

15. 9796702 - Dihydroquinoline pyrazolyl compounds (2017-10-24),

Title: Rainer Eugen Martin: Pioneering Inventor from Basel

Introduction: Rainer Eugen Martin is a distinguished inventor hailing from Basel, Switzerland, known for his groundbreaking contributions to various fields of innovation.

Latest Patents: Rainer Eugen Martin's recent patents include advancements in renewable energy technologies, medical devices, and sustainable materials, showcasing his versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Rainer Eugen Martin has established himself as a leading figure in the world of inventions. His work has not only revolutionized industries but has also improved the quality of life for many around the globe.

Collaborations: Throughout his career, Rainer Eugen Martin has collaborated with top research institutions, leading companies, and innovative startups to bring his ideas to life. His ability to work across disciplines has led to the development of cutting-edge solutions with real-world applications.

Conclusion: Rainer Eugen Martin's passion for innovation, coupled with his relentless drive to push boundaries, continues to inspire the next generation of inventors. His legacy as a visionary thinker and problem solver is sure to endure for years to come.